Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Rua Bioscience psilocybin study targets meth addiction
Markets

Rua Bioscience psilocybin study targets meth addiction

The ‘preparation step’ will be followed by an ‘experiential session’ with the mushroom.

Gregor Thompson 21 Jan 2025
Pacific Edge shares fall 63% after Novitas decision
Markets

Pacific Edge shares fall 63% after Novitas decision

Pacific Edge had $28.5m in reserves as at the end of December 2024. 

Rebecca Howard 13 Jan 2025
Democrats cite Samoan tragedy in bid to stop RFK
Politics

Democrats cite Samoan tragedy in bid to stop RFK

Measles killed dozens after Apia meeting with anti-vax activists.

Health New Zealand seeks chief executive
Editor's Picks

Health New Zealand seeks chief executive

The under-fire agency is launching a global search. The existing CEO can also reapply.

Oliver Lewis 10 Jan 2025